Search Results - "Korobko, I V"

Refine Results
  1. 1

    Interaction between MAK-V protein kinase and synaptopodin by Kalinichenko, S. V, Vikhreva, P. N, Korobko, I. V

    Published in Biochemistry (Moscow) (01-02-2011)
    “…MAK-V protein kinase (also known as HUNK) was discovered more than decade ago but its functions and molecular mechanisms of action still remain mostly unknown…”
    Get full text
    Journal Article
  2. 2

    Designing Multipurpose Diagnostic Units on the Basis of AFE Interfaces by Korenevskiy, N. A., Milostnaya, N. A., Nikolaev, V. N., Podmasteryev, K. V., Dreyzin, V. E., Eremenko, V. T., Koskin, A. V., Korobko, V. I.

    Published in Biomedical engineering (01-11-2016)
    “…The use of AFE interfaces in medical diagnostic equipment, including multipurpose devices, is discussed…”
    Get full text
    Journal Article
  3. 3

    Combination of ARE and HRE cis-Regulatory Elements Elevates the Activity of Tumor-Specific hTERT Promoter by Kalinichenko, S. V., Korobko, I. V., Shepelev, M. V.

    Published in Molecular biology (New York) (01-07-2021)
    “…Tumor-specific promoters and cis -regulatory genetic elements are used for transcriptional control of therapeutic transgene expression in cancer gene therapy…”
    Get full text
    Journal Article
  4. 4

    Mutations in the Effector Domain of RhoV GTPase Impair Its Binding to Pak1 Protein Kinase by Korobko, I. V., Shepelev, M. V.

    Published in Molecular biology (New York) (01-07-2018)
    “…Atypical RhoV GTPase (Chp/Wrch-2) is a member of the human Rho GTPase family, which belongs to the superfamily of Ras-related small GTPases. The biological…”
    Get full text
    Journal Article
  5. 5

    An Optimized Electroporation-Free Method for Generation of Recombinant Adenoviral Plasmids by Shepelev, M. V., Korobko, I. V.

    “…Recombinant adenoviruses are widely used for delivery and expression of transgenes for therapeutic purposes and in fundamental research. AdEasy™ adenoviral…”
    Get full text
    Journal Article
  6. 6

    Production of Recombinant Proteins in the Milk of Transgenic Animals: Current State and Prospects by Shepelev, M V, Kalinichenko, S V, Deykin, A V, Korobko, I V

    Published in Actanaturae (01-07-2018)
    “…The use of transgenic animals as bioreactors for the synthesis of the recombinant proteins secreted into milk is a current trend in the development of…”
    Get full text
    Journal Article
  7. 7

    mTOR-dependent transcriptional repression of Pdcd4 tumor suppressor in lung cancer cells by Vikhreva, P.N., Shepelev, M.V., Korobko, I.V.

    Published in Biochimica et biophysica acta (01-01-2014)
    “…Programmed cell death 4 (Pdcd4) tumor suppressor is frequently lost in tumors of various origins including lung cancer, and its loss contributes to tumor…”
    Get full text
    Journal Article
  8. 8

    Pak6 protein kinase is a novel effector of an atypical Rho family GTPase Chp/RhoV by Shepelev, M. V., Korobko, I. V.

    Published in Biochemistry (Moscow) (2012)
    “…Chp/RhoV is an atypical Rho GTPase whose functions are far from being fully understood. To date several effector proteins of Chp have been identified,…”
    Get full text
    Journal Article
  9. 9

    Xenobiotic Response Elements (XREs) from Human CYP1A1 Gene Enhance the hTERT Promoter Activity by Shepelev, M. V., Kalinichenko, S. V., Saakian, E. K., Korobko, I. V.

    Published in Doklady. Biochemistry and biophysics (01-03-2019)
    “…A hybrid 6XRE–hTERT promoter consisting of the hTERT tumor-specific promoter and six copies of the XRE element from the CYP1A1 human gene promoter was created…”
    Get full text
    Journal Article
  10. 10

    Pdcd4 tumor suppressor: Properties, functions, and possible applications in oncology by Vikhreva, P. N, Shepelev, M. V, Korobko, E. V, Korobko, I. V

    “…The inactivation of tumor suppressors and activation of protooncogenes are critical events in malignant cell transformation and tumor progression. Pdcd4…”
    Get full text
    Journal Article
  11. 11

    Human Antithrombin III Minigene with an Optimized Splicing Pattern by Shepelev, M. V., Saakian, E. K., Kalinichenko, S. V., Korobko, I. V.

    Published in Molecular biology (New York) (01-05-2019)
    “…Antithrombin III (AT3) belongs to the superfamily of serine protease inhibitors (serpins) and is a major anticoagulant in physiological conditions. Based on…”
    Get full text
    Journal Article
  12. 12

    Insertion of Multiple Artificial Introns of Universal Design into CDNA during Minigene Construction Assures Correct Transgene Splicing by Shepelev, M. V., Tikhonov, M. V., Kalinichenko, S. V., Korobko, I. V.

    Published in Molecular biology (New York) (01-05-2018)
    “…The presence of introns is often required for efficient transgene expression. The use of full-length genes for transgenesis is associated with technical…”
    Get full text
    Journal Article
  13. 13

    Insertion of Multiple Artificial Introns of Universal Design into cDNA during Minigene Construction Assures Correct Transgene Splicing by Shepelev, M V, Tikhonov, M V, Kalinichenko, S V, Korobko, I V

    Published in Molekuliarnaia biologiia (01-05-2018)
    “…The presence of introns is often required for efficient transgene expression. The use of full-length genes for transgenesis is associated with technical…”
    Get more information
    Journal Article
  14. 14

    Optimal artificial mini-introns for transgenic expression in the cells of mice and hamsters by Tikhonov, M. V., Maksimenko, O. G., Georgiev, P. G., Korobko, I. V.

    Published in Molecular biology (New York) (01-07-2017)
    “…Introns can frequently enhance transgene expression, and sometimes they are absolutely substantial. Based on an analysis of murine genes, in which mRNA does…”
    Get full text
    Journal Article
  15. 15
  16. 16

    A Novel Hybrid Promoter ARE-hTERT for Cancer Gene Therapy by Kalinichenko, S V, Shepelev, M V, Vikhreva, P N, Korobko, I V

    Published in Actanaturae (01-10-2017)
    “…describe a novel hybrid tumor-specific promoter, ARE-hTERT, composed of the human gene promoter (hTERT) and the antioxidant response element (ARE) from the…”
    Get full text
    Journal Article
  17. 17

    GMOs in Russia: Research, Society and Legislation by Korobko, I V, Georgiev, P G, Skryabin, K G, Kirpichnikov, M P

    Published in Actanaturae (01-10-2016)
    “…Russian legislation lags behind the rapid developments witnessed in genetic engineering. Only a scientifically based and well-substantiated policy on the place…”
    Get full text
    Journal Article
  18. 18

    Characterization of Rabaptin-5 γ isoform by Korobko, E. V., Kiselev, S. L., Korobko, I. V.

    Published in Biochemistry (Moscow) (01-09-2014)
    “…Rab GTPases are key regulators of intracellular membrane traffic acting through their effector molecules. Rabaptin-5 is a Rab5 effector in early endosome…”
    Get full text
    Journal Article
  19. 19

    Enhanced Vector Design for Cancer Gene Therapy with Hierarchical Enhancement of Therapeutic Transgene Expression by Kostina, M B, Sass, A V, Stukacheva, E A, Korobko, I V, Sverdlov, E D

    Published in Human gene therapy. Part B. Methods (01-10-2017)
    “…A set of vectors for Cre recombinase-dependent expression of the hybrid suicidal FCU1 transgene was constructed, including a two-plasmid system wherein the…”
    Get more information
    Journal Article
  20. 20

    Selection of microRNA for providing tumor specificity of transgene expression in cancer gene therapy by Shepelev, M. V., Kalinichenko, S. V., Vikhreva, P. N., Korobko, I. V.

    Published in Molecular biology (New York) (01-03-2016)
    “…The use of tumor-specific microRNA loss to inhibit transgene expression in normal cells is considered as a way to increase the specificity of gene-therapeutic…”
    Get full text
    Journal Article